TL;DR: The cannabis sector heads into Tuesday’s session with MSOS maintaining a constructive technical posture above its 50-day moving average, supported by improving market structure and a Q2 earnings catalyst window that opens in earnest for major multi-state operators beginning late July. Morning pre-session indicators suggest consolidation following Monday’s session, with institutional positioning data pointing toward selective accumulation in large-cap MSOs ahead of what analysts broadly expect to be a pivotal Q2 reporting cycle.
Market Analysis
The AdvisorShares Pure US Cannabis ETF (MSOS) enters Tuesday’s session in a technically constructive position after logging consecutive weekly gains throughout the first two weeks of July 2026. The ETF has been testing a multi-month resistance zone that, if broken convincingly, would represent the highest sustained close since the sector’s spring 2024 rally peak.
Monday’s session saw MSOS hold its ground above the critical $9.80 support level while volume remained below its 20-day average — a pattern consistent with controlled consolidation rather than distribution. For sector participants, the combination of light sell-side volume and improving relative strength against the broader market represents a constructive backdrop heading into what is shaping up as the most significant fundamental catalyst period of the calendar year.
Among the large-cap MSO constituents, price action remains differentiated. Green Thumb Industries (GTBIF) continues to demonstrate above-average relative strength within the ETF, supported by its Illinois-anchored revenue base and margin profile that ranks among the best in the peer group. Curaleaf Holdings (CURLF), meanwhile, is digesting its own pre-earnings setup with the market closely monitoring international revenue contribution from the company’s European operations — a strategic diversification play that adds a layer of complexity to Q2 modeling.
Trulieve Cannabis (TCNNF), which has been testing its 52-week high range, saw intraday reversal signals during Monday’s session that bear watching. The stock’s elevated short interest combined with a potential breakout through technical resistance creates a binary setup for Q2 earnings, which the company has scheduled for August 6. Any positive earnings surprise at Trulieve against the current technical backdrop could accelerate momentum across the broader MSOS complex.
Verano Holdings (VRNOF) is tracking near its multi-week high after Tuesday’s open. The company’s dense multi-state retail footprint — with particular concentration in Illinois, New Jersey, and Pennsylvania — positions it well to capture ongoing market share gains in adult-use states where dispensary licensing remains constrained. Verano’s Q2 report, expected in the first week of August, is likely to reflect sequential revenue improvement as New Jersey adult-use volumes ramp.
Check the cannabis stock tracker for real-time price updates across CURLF, GTBIF, TCNNF, VRNOF, and the full MSOS component list.
Regulatory and Market Context
The macroeconomic backdrop remains moderately supportive for cannabis sector risk assets as of mid-July 2026. The Federal Reserve’s current policy stance has eased pressure on small-cap growth equities broadly, a dynamic that has allowed cannabis stocks — which trade largely outside the traditional institutional equity complex — to benefit from improving risk appetite among specialist and retail participants alike.
On the regulatory front, the cannabis rescheduling process under the Controlled Substances Act continues to move through its administrative review cycle. While no final rule implementation date has been confirmed by the DEA or the Department of Justice as of this writing, the sector continues to trade on the expectation that formal Schedule III designation remains on the horizon. The primary near-term impact of rescheduling — the elimination of the Section 280E federal tax burden for plant-touching cannabis businesses — would be transformational for MSO cash flow profiles and represents the most significant structural catalyst the sector has seen in years.
State-level regulatory developments continue to support the demand picture. Missouri adult-use sales have continued to post record monthly figures, while New York’s adult-use market is expanding its licensed retail footprint at an accelerating pace, adding dispensary locations that benefit vertically integrated operators with existing cultivation and processing infrastructure in the state.
Investor attention is also shifting toward the upcoming earnings calendar. The combination of Q2 results from major MSOs and any concurrent regulatory developments in Washington creates an unusually dense information environment for the sector over the next three to four weeks. Positioning ahead of this window, particularly in stocks with historically high short interest, may drive volatility that extends beyond fundamentals.
Conclusion
The cannabis sector enters Tuesday’s trading session with a technically intact bull case and a fundamental catalyst calendar that could drive meaningful price discovery for MSO investors over the next four weeks. The Q2 earnings cycle is shaping up as a critical test of whether the sector’s improved technical posture reflects durable institutional conviction or near-term positioning ahead of event risk.
For investors tracking the space, the key variables to monitor are MSOS volume patterns relative to price action at current resistance levels, any DEA or DOJ statement on the rescheduling timeline, and early Q2 guidance commentary from the first MSOs to report. The setup is constructive; execution will determine whether July ends as a launching pad or a distribution phase for the year’s second half.